268 related articles for article (PubMed ID: 31015006)
1. Nose-to-brain delivery of levetiracetam after intranasal administration to mice.
Gonçalves J; Bicker J; Gouveia F; Liberal J; Oliveira RC; Alves G; Falcão A; Fortuna A
Int J Pharm; 2019 Jun; 564():329-339. PubMed ID: 31015006
[TBL] [Abstract][Full Text] [Related]
2. Pre-Clinical Assessment of the Nose-to-Brain Delivery of Zonisamide After Intranasal Administration.
Gonçalves J; Alves G; Carona A; Bicker J; Vitorino C; Falcão A; Fortuna A
Pharm Res; 2020 Mar; 37(4):74. PubMed ID: 32215749
[TBL] [Abstract][Full Text] [Related]
3. Intranasal administration of carbamazepine to mice: a direct delivery pathway for brain targeting.
Serralheiro A; Alves G; Fortuna A; Falcão A
Eur J Pharm Sci; 2014 Aug; 60():32-9. PubMed ID: 24813112
[TBL] [Abstract][Full Text] [Related]
4. Demonstration of Direct Nose-to-Brain Transport of Unbound HIV-1 Replication Inhibitor DB213 Via Intranasal Administration by Pharmacokinetic Modeling.
Wang Q; Zhang Y; Wong CH; Edwin Chan HY; Zuo Z
AAPS J; 2017 Dec; 20(1):23. PubMed ID: 29282567
[TBL] [Abstract][Full Text] [Related]
5. Is intranasal administration an opportunity for direct brain delivery of lacosamide?
Gonçalves J; Alves G; Fonseca C; Carona A; Bicker J; Falcão A; Fortuna A
Eur J Pharm Sci; 2021 Feb; 157():105632. PubMed ID: 33152466
[TBL] [Abstract][Full Text] [Related]
6. Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery.
Hao J; Zhao J; Zhang S; Tong T; Zhuang Q; Jin K; Chen W; Tang H
Colloids Surf B Biointerfaces; 2016 Nov; 147():376-386. PubMed ID: 27566226
[TBL] [Abstract][Full Text] [Related]
7. Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles.
Nigam K; Kaur A; Tyagi A; Nematullah M; Khan F; Gabrani R; Dang S
Drug Deliv Transl Res; 2019 Oct; 9(5):879-890. PubMed ID: 30887226
[TBL] [Abstract][Full Text] [Related]
8. Intranasal delivery of ciprofloxacin to rats: A topical approach using a thermoreversible in situ gel.
Sousa J; Alves G; Oliveira P; Fortuna A; Falcão A
Eur J Pharm Sci; 2017 Jan; 97():30-37. PubMed ID: 27810560
[TBL] [Abstract][Full Text] [Related]
9. Nose-to-Brain Delivery of Diazepam from an Intranasal Aqua-Triggered In-Situ (ATIS) Gelling Microemulsion: Monitoring Brain Uptake by Microdialysis.
Bachhav SS; Dighe V; Mali N; Gogtay NJ; Thatte UM; Devarajan PV
Eur J Drug Metab Pharmacokinet; 2020 Dec; 45(6):785-799. PubMed ID: 32813265
[TBL] [Abstract][Full Text] [Related]
10. Intranasal delivery of lipid-based nanosystems as a promising approach for brain targeting of the new-generation antiepileptic drug perampanel.
Meirinho S; Rodrigues M; Ferreira CL; Oliveira RC; Fortuna A; Santos AO; Falcão A; Alves G
Int J Pharm; 2022 Jun; 622():121853. PubMed ID: 35623483
[TBL] [Abstract][Full Text] [Related]
11. Intranasal mucoadhesive microemulsions of clonazepam: preliminary studies on brain targeting.
Vyas TK; Babbar AK; Sharma RK; Singh S; Misra A
J Pharm Sci; 2006 Mar; 95(3):570-80. PubMed ID: 16419051
[TBL] [Abstract][Full Text] [Related]
12. Comparison of pharmacokinetics of intragastrically and intrarectally administered levetiracetam tablets in healthy non-epileptic dogs.
Takamura H; Chongphaibulpatana P; Uzuka Y
Pol J Vet Sci; 2020 Dec; 23(4):491-494. PubMed ID: 33480487
[TBL] [Abstract][Full Text] [Related]
13. Non-invasive intranasal delivery of quetiapine fumarate loaded microemulsion for brain targeting: Formulation, physicochemical and pharmacokinetic consideration.
Shah B; Khunt D; Misra M; Padh H
Eur J Pharm Sci; 2016 Aug; 91():196-207. PubMed ID: 27174656
[TBL] [Abstract][Full Text] [Related]
14. Brain targeting studies on buspirone hydrochloride after intranasal administration of mucoadhesive formulation in rats.
Khan S; Patil K; Yeole P; Gaikwad R
J Pharm Pharmacol; 2009 May; 61(5):669-75. PubMed ID: 19406007
[TBL] [Abstract][Full Text] [Related]
15. Direct nose-to-brain delivery of lamotrigine following intranasal administration to mice.
Serralheiro A; Alves G; Fortuna A; Falcão A
Int J Pharm; 2015 Jul; 490(1-2):39-46. PubMed ID: 25979854
[TBL] [Abstract][Full Text] [Related]
16. Nanoemulsion-based intranasal drug delivery system of saquinavir mesylate for brain targeting.
Mahajan HS; Mahajan MS; Nerkar PP; Agrawal A
Drug Deliv; 2014 Mar; 21(2):148-54. PubMed ID: 24128122
[TBL] [Abstract][Full Text] [Related]
17. Direct nose-brain transport of benzoylecgonine following intranasal administration in rats.
Chow HH; Anavy N; Villalobos A
J Pharm Sci; 2001 Nov; 90(11):1729-35. PubMed ID: 11745730
[TBL] [Abstract][Full Text] [Related]
18. Serum levetiracetam concentrations after transdermal levetiracetam administration, 3 times daily, to healthy cats.
Smith C; Barnes Heller HL; Reif N; Van Hesteren M; Reinhart JM
J Vet Intern Med; 2019 Mar; 33(2):827-830. PubMed ID: 30663797
[TBL] [Abstract][Full Text] [Related]
19. Formulation of intranasal mucoadhesive temperature-mediated in situ gel containing ropinirole and evaluation of brain targeting efficiency in rats.
Khan S; Patil K; Bobade N; Yeole P; Gaikwad R
J Drug Target; 2010 Apr; 18(3):223-34. PubMed ID: 20030503
[TBL] [Abstract][Full Text] [Related]
20. Chitosan and cyclodextrin in intranasal microemulsion for improved brain buspirone hydrochloride pharmacokinetics in rats.
Bshara H; Osman R; Mansour S; El-Shamy Ael-H
Carbohydr Polym; 2014 Jan; 99():297-305. PubMed ID: 24274510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
